<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Genomics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Genomics</journal-id>
    <journal-title-group>
      <journal-title>BMC Genomics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2164</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9082955</article-id>
    <article-id pub-id-type="publisher-id">8537</article-id>
    <article-id pub-id-type="doi">10.1186/s12864-022-08537-1</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Genome-wide identification of associations between enhancer and alternative splicing in human and mouse</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Shiau</surname>
          <given-names>Cheng-Kai</given-names>
        </name>
        <address>
          <email>shiauck@gmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Huang</surname>
          <given-names>Jia-Hsin</given-names>
        </name>
        <address>
          <email>jiahsin.huang@gmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Yu-Ting</given-names>
        </name>
        <address>
          <email>meow23571379@gmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4200-8137</contrib-id>
        <name>
          <surname>Tsai</surname>
          <given-names>Huai-Kuang</given-names>
        </name>
        <address>
          <email>hktsai@iis.sinica.edu.tw</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.28665.3f</institution-id><institution-id institution-id-type="ISNI">0000 0001 2287 1366</institution-id><institution>Institute of Information Science, </institution><institution>Academia Sinica, </institution></institution-wrap>Taipei, 115 Taiwan </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.28665.3f</institution-id><institution-id institution-id-type="ISNI">0000 0001 2287 1366</institution-id><institution>Bioinformatics Program, International Graduate Program, </institution><institution>Academia Sinica, </institution></institution-wrap>Taipei, 115 Taiwan </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.260539.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2059 7017</institution-id><institution>Institute of Biomedical Informatics, </institution><institution>National Yang Ming Chiao Tung University, </institution></institution-wrap>Taipei, 115 Taiwan </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>9</day>
      <month>5</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>9</day>
      <month>5</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2021</year>
    </pub-date>
    <volume>22</volume>
    <issue>Suppl 5</issue>
    <issue-sponsor>Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests.</issue-sponsor>
    <elocation-id>919</elocation-id>
    <history>
      <date date-type="received">
        <day>7</day>
        <month>4</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>7</day>
        <month>4</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Â© The Author(s) 2022</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">Alternative splicing (AS) increases the diversity of transcriptome and could fine-tune the function of genes, so that understanding the regulation of AS is vital. AS could be regulated by many different <italic>cis</italic>-regulatory elements, such as enhancer. Enhancer has been experimentally proved to regulate AS in some genes. However, there is a lack of genome-wide studies on the association between enhancer and AS (enhancer-AS association). To bridge the gap, here we developed an integrative analysis on a genome-wide scale to identify enhancer-AS associations in human and mouse.</p>
      </sec>
      <sec>
        <title>Result</title>
        <p id="Par2">We collected enhancer datasets which include 28 human and 24 mouse tissues and cell lines, and RNA-seq datasets which are paired with the selected tissues. Combining with data integration and statistical analysis, we identified 3,242 human and 7,716 mouse genes which have significant enhancer-AS associations in at least one tissue. On average, for each gene, about 6% of enhancers in human (5% in mouse) are associated to AS change and for each enhancer, approximately one gene is identified to have enhancer-AS association in both human and mouse. We found that 52% of the human significant (34% in mouse) enhancer-AS associations are the co-existence of homologous genes and homologous enhancers. We further constructed a user-friendly platform, named Visualization of Enhancer-associated Alternative Splicing (VEnAS, <ext-link ext-link-type="uri" xlink:href="http://venas.iis.sinica.edu.tw/">http://venas.iis.sinica.edu.tw/</ext-link>), to provide genomic architecture, intuitive association plot, and contingency table of the significant enhancer-AS associations.</p>
      </sec>
      <sec>
        <title>Conclusion</title>
        <p id="Par3">This study provides the first genome-wide identification of enhancer-AS associations in human and mouse. The results suggest that a notable portion of enhancers are playing roles in AS regulations. The analyzed results and the proposed platform VEnAS would provide a further understanding of enhancers on regulating alternative splicing.</p>
      </sec>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s12864-022-08537-1.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Enhancer</kwd>
      <kwd>Alternative splicing</kwd>
      <kwd>Association analysis</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004663</institution-id>
            <institution>Ministry of Science and Technology, Taiwan</institution>
          </institution-wrap>
        </funding-source>
        <award-id>MOST108-2221-E-001-014-MY3</award-id>
        <principal-award-recipient>
          <name>
            <surname>Tsai</surname>
            <given-names>Huai-Kuang</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <conference xlink:href="http://www.binfo.ncku.edu.tw/APBC2021/">
      <conf-name>The 19th Asia Pacific Bioinformatics Conference (APBC 2021)</conf-name>
      <conf-acronym>APBC 2021</conf-acronym>
      <conf-loc>Tainan, Taiwan</conf-loc>
      <conf-date>3-5 February 2021</conf-date>
    </conference>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>Â© The Author(s) 2021</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par22">Alternative splicing (AS) is one of the important processes during RNA maturation in higher eukaryotes. By including or excluding alternative exons, AS increases the diversity of downstream RNA products. More than 90% of genes with multiple exons undergo AS [<xref ref-type="bibr" rid="CR1">1</xref>]. The inclusion and exclusion of exons by AS shape the downstream protein diversity [<xref ref-type="bibr" rid="CR2">2</xref>]. Furthermore, AS participates in many key biological processes, such as developmental stages [<xref ref-type="bibr" rid="CR3">3</xref>], tissue types [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>], genders [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>], insect caste determination [<xref ref-type="bibr" rid="CR8">8</xref>], and so on. Thus, understanding the regulation of AS is vital.</p>
    <p id="Par23">The regulation of AS relies on numerous <italic>cis</italic>-regulatory elements, including <italic>cis</italic>-acting splicing regulatory elements (SREs), splicing motifs, and enhancers. SREs include exonic/intronic splicing enhancers or silencers. Wang et al. had conducted a systematical method for the identification of these SREs [<xref ref-type="bibr" rid="CR9">9</xref>]. Some splicing motifs have been reported to be correlated with regulation of AS. For example, Holste et al. had provided a computational framework to identify splicing motifs and to predict AS events [<xref ref-type="bibr" rid="CR10">10</xref>]. Enhancer had also been reported to correlate to AS changes [<xref ref-type="bibr" rid="CR11">11</xref>â<xref ref-type="bibr" rid="CR13">13</xref>].</p>
    <p id="Par24">Enhancer is a <italic>cis</italic>-regulatory element known as its characteristics: high abundance in genome, regulating genes in highly variable location, and lack of discriminative DNA sequence [<xref ref-type="bibr" rid="CR14">14</xref>]. Enhancers have been demonstrated to physically interact with promoter and polymerase during transcription elongation [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. This physical interaction shortens the distance between enhancer and gene body, and further grants enhancers an opportunity to influence AS. Previous studies had demonstrated that enhancer can affect alternative splicing. For example, the insertion of the SV40 transcriptional enhancer is capable of inhibition of inclusive form of fibronectin extra domain I [<xref ref-type="bibr" rid="CR11">11</xref>]. Another one example is that the downstream enhancer of protocadherin alpha can loop back to bind with promoter by coupling of CTCF and further affect AS [<xref ref-type="bibr" rid="CR17">17</xref>]. These studies had shown that enhancer is capable of affecting AS events.</p>
    <p id="Par25">A previous study suggested that most of enhancers are inactive (poised) until the proper factor binds on it [<xref ref-type="bibr" rid="CR18">18</xref>]. Thus, it is challenging for biologists to design a high-throughput experiment to identify the enhancer-AS associations. Because there is no genome-wide study to identify the associations, in this context, we developed a bioinformatics pipeline (Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>A) to find out the significant enhancer-AS associations on a genome-wide scale by analyzing large amount of human and mouse transcriptomes. We further constructed a platform entitled VEnAS (Visualization of Enhancer-associated Alternative Splicing) to present the enhancer-AS associations.<fig id="Fig1"><label>Fig. 1</label><caption><p>(<bold>A</bold>)Workflow or the analysis pipeline for identification of enhancer-AS associations.Â In the top left part of the analysis pipeline, we focused on enhancer datasets polish, including position refining and presence/absence calling. In the top right part, we focused on the processes for quantification of AS changes. We then conducted association analysis to identify enhancer-AS associations, and finally constructed a website called VEnAS for data visualization. (<bold>B</bold>)Â An example of refining enhancers between different tissues and cell lines.The blue boxes are representing to enhancers in different tissues or cell lines. The middle positions of enhancers are used for hierarchical clustering with centroid method. The cuttree threshold is set as 3 kilo bases. The green and orange boxes are representing to the two refined groups under the threshold</p></caption><graphic xlink:href="12864_2022_8537_Fig1_HTML" id="MO1"/></fig></p>
  </sec>
  <sec id="Sec2">
    <title>Methods</title>
    <sec id="Sec3">
      <title>Data selection and preparation</title>
      <p id="Par26">We downloaded enhancer datasets which include 28 human and 24 mouse tissues and cell lines from enhancerAtlas [<xref ref-type="bibr" rid="CR19">19</xref>]. These tissues and cell lines were chosen because they have at least three paired RNA-seq datasets for quantification of AS. To prevent the data imbalance, we down-sampled the number of RNA-seq datasets to three. We then downloaded the chosen 84 human (28*3) and 72 mouse (24*3) RNA-seq fastq files from Sequence Read Archive (SRA) [<xref ref-type="bibr" rid="CR20">20</xref>]. These fastq files were mapped onto the latest genome (GRCh38 for human and GRCm38 for mouse) by HISAT2 [<xref ref-type="bibr" rid="CR21">21</xref>] with default parameters.</p>
    </sec>
    <sec id="Sec4">
      <title>Enhancer calling</title>
      <p id="Par27">The boundaries of enhancer could be incongruent due to tissue characteristics, enhancer calling methodologies, or batch effects from input data sets. Thus, refining the location of enhancers between different tissue types is required to eradicate the incongruence. To refine the enhancers between different tissues and cell lines, we took advantage of agglomerative hierarchical clustering with centroid method (Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>B). We used the central position of each enhancer as input for hierarchical clustering. Previous studies had reported that the length of enhancer is ranged between 2â4 kilo bases [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR22">22</xref>â<xref ref-type="bibr" rid="CR24">24</xref>]. Thus, we set 3 kilo bases as a threshold to limit the growth of the clusters. After refining the location of enhancer, we were able to call the present or absent of enhancer between different tissues based on whether there is any enhancer located in the refined range.</p>
    </sec>
    <sec id="Sec5">
      <title>Quantification and categorization of AS</title>
      <p id="Par28">The v94 human and mouse genome annotations were downloaded from Ensembl. CATANA [<xref ref-type="bibr" rid="CR25">25</xref>] was used upon the human and mouse genome annotation to obtain the latest version of AS annotation. The latest AS annotation and the mapped bam files (from data preparation) were used for MISO [<xref ref-type="bibr" rid="CR26">26</xref>] to compute percent splice in (PSI), which is an inclusion index based on the number of junction reads [<xref ref-type="bibr" rid="CR27">27</xref>]. The equation of PSI is defined as<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{PSI}} \, \text{=} \, \frac{\text{Junction reads supporting to inclusive form}}{\left(\text{Junction reads supporting to inclusive form}\text{ + Junction reads supporting to exclusive form}\right)}$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:mtext>PSI</mml:mtext><mml:mspace width="0.166667em"/><mml:mtext>=</mml:mtext><mml:mspace width="0.166667em"/><mml:mfrac><mml:mrow><mml:mtext>Junction reads supporting to inclusive form</mml:mtext></mml:mrow><mml:mfenced close=")" open="("><mml:mtext>Junction reads supporting to inclusive form + Junction reads supporting to exclusive form</mml:mtext></mml:mfenced></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="12864_2022_8537_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par29">To guarantee the AS changes of a given AS event from human 84 or mouse 72 samples are large enough, we removed the AS events with the PSI range across all samples less than 0.1. After that, we conducted Z-transformation upon all PSI values across tissues to capture the changes of a given AS between tissues. To categorize whether a tissue does have an AS change, the tissue having Z-transformed PSI value (Z-PSI) larger than 1 is defined as âinclusive shiftâ, while the tissue having Z-PSI smaller than -1 is defined as âexclusive shiftâ.</p>
    </sec>
    <sec id="Sec6">
      <title>Association analysis</title>
      <p id="Par30">With the labels present/absent of enhancers and inclusive/exclusive shift of AS changes, for each enhancer-AS pair we can generate a two-by-two contingency table containing the number of samples in the four cells. We removed enhancer-AS pairs having low strength of association in the contingency table to improve the precision of the association analysis and reduce the false results. Thus, we only included the enhancer-AS pairs for analysis in which the odds ratio must be larger than 2 or less than 0.5 accompanied by the effective size constrain (the number difference between concordant and discordant cells must be larger than 10). Then the Fisher exact test was conducted exhaustively throughout all the enhancer-AS pairs to calculate the <italic>p</italic>-value. All the <italic>p</italic>-values were then adjusted by BenjaminiâHochberg procedure false discovery rate (FDR) to obtain <italic>q</italic>-values. An enhancer-AS association was considered significant if the <italic>q</italic>-value is smaller than 0.05.</p>
    </sec>
    <sec id="Sec7">
      <title>Implementation of VEnAS</title>
      <p id="Par31">The VEnAS database was written by a combination of Perl, Python, and R for data processing and statistical analysis. The web server of VEnAS was implemented with a combination of PHP, Google Polymer framework, and MySQL on Ubuntu server. For efficiently storing and querying, the analysis result and other integrated data were subjected to database normalization. The schema of the normalized MySQL database table is shown in the Figure <xref rid="MOESM1" ref-type="media">S1</xref>. The tables holding PSI and genomic location of enhancer were separated for parallel querying by MySQL. In addition, the table holding index for autocompletion during user query is shown on the top-left side of FigureÂ <xref rid="MOESM1" ref-type="media">S1</xref>. The keywords used for constructing index include Ensembl gene accession, gene symbol, and gene description.</p>
    </sec>
  </sec>
  <sec id="Sec8">
    <title>Results</title>
    <p id="Par32">To identify the enhancer-AS associations on a genome-wide scale, we developed an analysis pipeline (Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>A, detailed in Methods). We first curated the enhancer profiles and RNA-seq datasets of 28 human and 24 mouse tissues and cell lines for analysis. Since the profile of active enhancer is naturally varied between different tissues and cell lines [<xref ref-type="bibr" rid="CR28">28</xref>], we refined the boundaries of enhancers and generated enhancer calling using the hierarchical clustering method. We then used CATANA and MISO to quantify and categorize AS events from RNA-seq datasets. To further check the similarity or overlapping event between different samples, we computed the Jaccard coefficient index (Figure <xref rid="MOESM1" ref-type="media">S2</xref>). The result shows that the enhancer-AS events are quite similar within the triplicated samples under the same tissue type but different between tissues. The Fisher exact test was performed to identify the significant enhancer-AS associations with present/absent of enhancer and inclusive/exclusive shift of AS types.</p>
    <sec id="Sec9">
      <title>Enhancer-AS associations in human and mouse</title>
      <p id="Par33">By conducting association analysis with absent/present of enhancer and inclusive/exclusive shift of AS event, we found that 3,242 human genes and 7,716 mouse genes have at least one significant enhancer-AS association, and 11,262 human enhancers and 26,083 mouse enhancers are participating in AS changes (Table <xref rid="Tab1" ref-type="table">1</xref> and Table <xref rid="Tab2" ref-type="table">2</xref>). Previous study had mentioned that transcripts having alternative start and termination sites shape the major transcriptome diversity across human tissues [<xref ref-type="bibr" rid="CR13">13</xref>]. As expected, in our results, the numbers of genes having associations between enhancers and the AS types regarding alternative transcription initiation and termination sites (AFE, ALE, ATSS and ATTS) are notably higher than the six canonical AS types (A5SS, A3SS, SE, RI, MSE, MXE) in human and mouse (Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>The counting table of human genes and enhancer having enhancers having enhancer-AS association for different AS types. The row âAllâ represents the number of genes or enhancers having associations in any types of AS. The column âinputâ means the number of genes or enhancers which are qualified for the analysis. The column âsignificantâ represents the number of genes or enhancers pass the <italic>q</italic>-value smaller than 0.05</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">AS type</th><th align="left"/><th align="left" colspan="3">Counting by genes</th><th align="left"/><th align="left" colspan="3">Counting by enhancers</th></tr><tr><th align="left"/><th align="left">Significant</th><th align="left">Input</th><th align="left">Percentage</th><th align="left"/><th align="left">Significant</th><th align="left">Input</th><th align="left">Percentage</th></tr></thead><tbody><tr><td align="left">A5SS</td><td align="left"/><td align="left">310</td><td align="left">732</td><td char="." align="char">42.35%</td><td align="left"/><td align="left">800</td><td align="left">4542</td><td char="." align="char">17.61%</td></tr><tr><td align="left">A3SS</td><td align="left"/><td align="left">327</td><td align="left">724</td><td char="." align="char">45.17%</td><td align="left"/><td align="left">911</td><td align="left">4727</td><td char="." align="char">19.27%</td></tr><tr><td align="left">SE</td><td align="left"/><td align="left">367</td><td align="left">1406</td><td char="." align="char">26.10%</td><td align="left"/><td align="left">807</td><td align="left">8610</td><td char="." align="char">9.37%</td></tr><tr><td align="left">RI</td><td align="left"/><td align="left">579</td><td align="left">977</td><td char="." align="char">59.26%</td><td align="left"/><td align="left">1882</td><td align="left">6896</td><td char="." align="char">27.29%</td></tr><tr><td align="left">MSE</td><td align="left"/><td align="left">276</td><td align="left">629</td><td char="." align="char">43.88%</td><td align="left"/><td align="left">826</td><td align="left">4267</td><td char="." align="char">19.36%</td></tr><tr><td align="left">MXE</td><td align="left"/><td align="left">209</td><td align="left">309</td><td char="." align="char">67.64%</td><td align="left"/><td align="left">727</td><td align="left">1757</td><td char="." align="char">41.38%</td></tr><tr><td align="left">AFE</td><td align="left"/><td align="left">1578</td><td align="left">2121</td><td char="." align="char">74.40%</td><td align="left"/><td align="left">6545</td><td align="left">15,695</td><td char="." align="char">41.70%</td></tr><tr><td align="left">ALE</td><td align="left"/><td align="left">860</td><td align="left">1858</td><td char="." align="char">46.29%</td><td align="left"/><td align="left">2466</td><td align="left">13,137</td><td char="." align="char">18.77%</td></tr><tr><td align="left">ATSS</td><td align="left"/><td align="left">2441</td><td align="left">3548</td><td char="." align="char">68.80%</td><td align="left"/><td align="left">7660</td><td align="left">25,654</td><td char="." align="char">29.86%</td></tr><tr><td align="left">ATTS</td><td align="left"/><td align="left">1890</td><td align="left">4011</td><td char="." align="char">47.12%</td><td align="left"/><td align="left">4861</td><td align="left">29,766</td><td char="." align="char">16.33%</td></tr><tr><td align="left">All</td><td align="left"/><td align="left">3242</td><td align="left">4658</td><td char="." align="char">69.60%</td><td align="left"/><td align="left">11,262</td><td align="left">35,158</td><td char="." align="char">32.03%</td></tr></tbody></table></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption><p>The counting table of mouse genes and enhancer having enhancer-AS association for different AS types. The row âAllâ represents the number of genes or enhancers having associations in any types of AS. The column âinputâ means the number of genes or enhancers which are qualified for the analysis. The column âsignificantâ represents the number of genes or enhancers pass the <italic>q</italic>-value smaller than 0.05</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">AS type</th><th align="left"/><th align="left" colspan="3">Counting by genes</th><th align="left"/><th align="left" colspan="3">Counting by enhancers</th></tr><tr><th align="left"/><th align="left">Significant</th><th align="left">Input</th><th align="left">Percentage</th><th align="left"/><th align="left">Significant</th><th align="left">Input</th><th align="left">Percentage</th></tr></thead><tbody><tr><td align="left">A5SS</td><td align="left"/><td align="left">541</td><td align="left">689</td><td char="." align="char">78.52%</td><td align="left"/><td align="left">1479</td><td align="left">2984</td><td char="." align="char">49.56%</td></tr><tr><td align="left">A3SS</td><td align="left"/><td align="left">315</td><td align="left">726</td><td char="." align="char">43.39%</td><td align="left"/><td align="left">560</td><td align="left">2969</td><td char="." align="char">18.86%</td></tr><tr><td align="left">SE</td><td align="left"/><td align="left">1158</td><td align="left">1530</td><td char="." align="char">75.69%</td><td align="left"/><td align="left">3183</td><td align="left">6319</td><td char="." align="char">50.37%</td></tr><tr><td align="left">RI</td><td align="left"/><td align="left">939</td><td align="left">1210</td><td char="." align="char">77.60%</td><td align="left"/><td align="left">2805</td><td align="left">5942</td><td char="." align="char">47.21%</td></tr><tr><td align="left">MSE</td><td align="left"/><td align="left">370</td><td align="left">484</td><td char="." align="char">76.45%</td><td align="left"/><td align="left">929</td><td align="left">1838</td><td char="." align="char">50.54%</td></tr><tr><td align="left">MXE</td><td align="left"/><td align="left">214</td><td align="left">247</td><td char="." align="char">86.64%</td><td align="left"/><td align="left">612</td><td align="left">986</td><td char="." align="char">62.07%</td></tr><tr><td align="left">AFE</td><td align="left"/><td align="left">2251</td><td align="left">2643</td><td char="." align="char">85.17%</td><td align="left"/><td align="left">7865</td><td align="left">14,387</td><td char="." align="char">54.67%</td></tr><tr><td align="left">ALE</td><td align="left"/><td align="left">1762</td><td align="left">2170</td><td char="." align="char">81.20%</td><td align="left"/><td align="left">5787</td><td align="left">11,067</td><td char="." align="char">52.29%</td></tr><tr><td align="left">ATSS</td><td align="left"/><td align="left">4967</td><td align="left">5593</td><td char="." align="char">88.81%</td><td align="left"/><td align="left">15,845</td><td align="left">27,158</td><td char="." align="char">58.34%</td></tr><tr><td align="left">ATTS</td><td align="left"/><td align="left">6167</td><td align="left">7158</td><td char="." align="char">86.16%</td><td align="left"/><td align="left">18,188</td><td align="left">36,008</td><td char="." align="char">50.51%</td></tr><tr><td align="left">All</td><td align="left"/><td align="left">7716</td><td align="left">8429</td><td char="." align="char">91.54%</td><td align="left"/><td align="left">26,083</td><td align="left">45,810</td><td char="." align="char">56.94%</td></tr></tbody></table></table-wrap><fig id="Fig2"><label>Fig. 2</label><caption><p>The counting number of genes and enhancer associated to AS changes in (<bold>A</bold>) human and (<bold>B</bold>) mouse. The number of genes having significant (FDR <italic>q</italic>-valueâ&lt;â0.05) enhancer-associated AS and the number of enhancers significantly (FDR <italic>q</italic>-valueâ&lt;â0.05) associated to AS changes are shown in x-axis. All ten types of AS are counted independently. Every gene having multiple significant events is counted once. The ten types of AS are including alternative 5â/3â splice site (A5SS, A3SS), skipped exon (SE), retained intron (RI), multiple skipped exons (MSE), mutually exclusive exons (MXE), alternative first/last exons (AFE, ALE), and alternative transcription start/termination sites (ATSS, ATTS)</p></caption><graphic xlink:href="12864_2022_8537_Fig2_HTML" id="MO2"/></fig></p>
      <p id="Par34">Gene and enhancer are many-to-many relationship [<xref ref-type="bibr" rid="CR29">29</xref>]. One given gene could be associated to multiple enhancers, and vice versa. Here we would like to know that under consideration of association with AS changes, how many enhancers are associated to one given gene and how many genes are associated to one given enhancer. We further interrogated the association relationship between enhancer and genes by examining the number of enhancers per gene (also the genes per enhancer). According to the annotation from enhancerAtlas, on average, each gene is paired with 60.32 enhancers in human and 68.47 enhancers in mouse. Our association analysis suggests that given one gene, on average, 3.88 of the 60.32 enhancers (6.43%) in human and 3.54 of the 68.47 enhancers (5.17%) in mouse are associated to AS change (Figure <xref rid="MOESM1" ref-type="media">S3</xref>A and <xref rid="MOESM1" ref-type="media">S3</xref>B). For enhancers, on average each one enhancer is paired to 7.66 genes in human and 9.29 genes in mouse according to enhancerAtlas, but in our result one enhancer is significantly associated to AS change with only 1.28 genes human and 1.22 genes in mouse (Figure <xref rid="MOESM1" ref-type="media">S3</xref>C and <xref rid="MOESM1" ref-type="media">S3</xref>D).</p>
    </sec>
    <sec id="Sec10">
      <title>Investigations of the genetic properties of identified enhancer-AS associations</title>
      <p id="Par35">To further understand the genetic properties of identified enhancer-AS associations, we observed the proportion of enhancer-AS associations which have both homologous genes and homologous enhancers between human and mouse. For each gene in human, we defined its homolog in mouse according to the homologs list provided in Mouse Genome Informatics (MGI) [<xref ref-type="bibr" rid="CR30">30</xref>]. For each enhancer in human, we obtained its homologous enhancers in mouse by conducting the CrossMap [<xref ref-type="bibr" rid="CR31">31</xref>] with the human and mouse chain file and, which is the pairwise alignment between two reference assemblies from Ensembl [<xref ref-type="bibr" rid="CR32">32</xref>]. We found that about 52% of the significant and 35% of the insignificant enhancer-AS associations in human have homologous genes accompanied with homologous enhancers in mouse (Table <xref rid="Tab3" ref-type="table">3</xref>). The Welch two sample t-test shows significant difference (<italic>p</italic>-valueâ=â5.56âÃâ10<sup>â11</sup>) upon percentages of significant enhancer-AS pairs with homologous genes and enhancers in all ten types of AS against insignificant groups. This suggests that the significant enhancer-AS pairs are more likely to be the co-existence of homologous genes and homologous enhancers than insignificant enhancer-AS pairs. Similar trends with lower percentages were found when we check the significant enhancer-AS pairs (Welch two sample t-test <italic>p</italic>-valueâ=â1.906âÃâ10<sup>â13</sup>) in mouse (Table <xref rid="Tab4" ref-type="table">4</xref>). These results show that the significant enhancer-AS associations we identified are more likely to be the co-existence of homologous genes accompanied with homologous enhancers in both human and mouse rather than conservation of enhancer sequence only.<table-wrap id="Tab3"><label>Table 3</label><caption><p>The counting table of human significant and insignificant enhancer-AS pairs accompanied with both homologous enhancers. The numbers of total significant enhancer-AS pairs, significant enhancer-AS pairs with homologous genes and enhancers, total insignificant enhancer-AS pairs, insignificant enhancer-AS pairs with homologous genes or enhancers in all ten types of AS are provided. The percentages of enhancer-AS pairs with homologous genes and enhancers in all ten types of AS are calculated</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">AS type</th><th align="left"/><th align="left">Significant pairs</th><th align="left">with homologous genes and enhancers</th><th align="left">Percentage</th><th align="left"/><th align="left">Insignificant pairs</th><th align="left">with homologous genes and enhancers</th><th align="left">Percentage</th></tr></thead><tbody><tr><td align="left">A5SS</td><td align="left"/><td align="left">1046</td><td align="left">553</td><td char="." align="char">52.87%</td><td align="left"/><td align="left">266,860</td><td align="left">97,639</td><td char="." align="char">36.59%</td></tr><tr><td align="left">A3SS</td><td align="left"/><td align="left">2129</td><td align="left">1122</td><td char="." align="char">52.70%</td><td align="left"/><td align="left">436,986</td><td align="left">160,042</td><td char="." align="char">36.62%</td></tr><tr><td align="left">SE</td><td align="left"/><td align="left">3070</td><td align="left">1631</td><td char="." align="char">53.13%</td><td align="left"/><td align="left">731,628</td><td align="left">256,762</td><td char="." align="char">35.09%</td></tr><tr><td align="left">RI</td><td align="left"/><td align="left">5792</td><td align="left">3115</td><td char="." align="char">53.78%</td><td align="left"/><td align="left">894,218</td><td align="left">319,572</td><td char="." align="char">35.74%</td></tr><tr><td align="left">MSE</td><td align="left"/><td align="left">6980</td><td align="left">3681</td><td char="." align="char">52.74%</td><td align="left"/><td align="left">930,339</td><td align="left">329,901</td><td char="." align="char">35.46%</td></tr><tr><td align="left">MXE</td><td align="left"/><td align="left">7950</td><td align="left">4124</td><td char="." align="char">51.87%</td><td align="left"/><td align="left">944,441</td><td align="left">332,218</td><td char="." align="char">35.18%</td></tr><tr><td align="left">AFE</td><td align="left"/><td align="left">38,481</td><td align="left">18,452</td><td char="." align="char">47.95%</td><td align="left"/><td align="left">3,672,503</td><td align="left">1,235,971</td><td char="." align="char">33.65%</td></tr><tr><td align="left">ALE</td><td align="left"/><td align="left">45,132</td><td align="left">21,118</td><td char="." align="char">46.79%</td><td align="left"/><td align="left">4,134,137</td><td align="left">1,377,293</td><td char="." align="char">33.32%</td></tr><tr><td align="left">ATSS</td><td align="left"/><td align="left">92,545</td><td align="left">47,260</td><td char="." align="char">51.07%</td><td align="left"/><td align="left">11,645,531</td><td align="left">4,181,752</td><td char="." align="char">35.91%</td></tr><tr><td align="left">ATTS</td><td align="left"/><td align="left">113,447</td><td align="left">59,169</td><td char="." align="char">52.16%</td><td align="left"/><td align="left">12,675,728</td><td align="left">4,528,278</td><td char="." align="char">35.72%</td></tr></tbody></table></table-wrap><table-wrap id="Tab4"><label>Table 4</label><caption><p>The counting table of mouse significant and insignificant enhancer-AS pairs accompanied with both homologous genes and homologous enhancers</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">AS type</th><th align="left"/><th align="left">Significant pairs</th><th align="left">with homologous genes and enhancers</th><th align="left">Percentage</th><th align="left"/><th align="left">Insignificant pairs</th><th align="left">with homologous genes and enhancers</th><th align="left">Percentage</th></tr></thead><tbody><tr><td align="left">A5SS</td><td align="left"/><td align="left">1648</td><td align="left">558</td><td char="." align="char">33.86%</td><td align="left"/><td align="left">387,866</td><td align="left">106,854</td><td char="." align="char">27.55%</td></tr><tr><td align="left">A3SS</td><td align="left"/><td align="left">2232</td><td align="left">787</td><td char="." align="char">35.26%</td><td align="left"/><td align="left">696,666</td><td align="left">196,317</td><td char="." align="char">28.18%</td></tr><tr><td align="left">SE</td><td align="left"/><td align="left">5963</td><td align="left">1975</td><td char="." align="char">33.12%</td><td align="left"/><td align="left">1,138,626</td><td align="left">308,850</td><td char="." align="char">27.12%</td></tr><tr><td align="left">RI</td><td align="left"/><td align="left">9662</td><td align="left">3363</td><td char="." align="char">34.81%</td><td align="left"/><td align="left">1,518,594</td><td align="left">421,336</td><td char="." align="char">27.75%</td></tr><tr><td align="left">MSE</td><td align="left"/><td align="left">10,670</td><td align="left">3674</td><td char="." align="char">34.43%</td><td align="left"/><td align="left">1,552,868</td><td align="left">429,533</td><td char="." align="char">27.66%</td></tr><tr><td align="left">MXE</td><td align="left"/><td align="left">11,276</td><td align="left">3883</td><td char="." align="char">34.44%</td><td align="left"/><td align="left">1,556,723</td><td align="left">430,275</td><td char="." align="char">27.64%</td></tr><tr><td align="left">AFE</td><td align="left"/><td align="left">32,678</td><td align="left">10,732</td><td char="." align="char">32.84%</td><td align="left"/><td align="left">3,796,988</td><td align="left">985,494</td><td char="." align="char">25.95%</td></tr><tr><td align="left">ALE</td><td align="left"/><td align="left">44,033</td><td align="left">14,500</td><td char="." align="char">32.93%</td><td align="left"/><td align="left">4,133,025</td><td align="left">1,067,346</td><td char="." align="char">25.82%</td></tr><tr><td align="left">ATSS</td><td align="left"/><td align="left">100,364</td><td align="left">34,303</td><td char="." align="char">34.18%</td><td align="left"/><td align="left">12,505,889</td><td align="left">3,380,938</td><td char="." align="char">27.03%</td></tr><tr><td align="left">ATTS</td><td align="left"/><td align="left">164,111</td><td align="left">56,071</td><td char="." align="char">34.17%</td><td align="left"/><td align="left">13,450,641</td><td align="left">3,630,266</td><td char="." align="char">26.99%</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec11">
      <title>Visualization of enhancer-AS associations</title>
      <p id="Par36">To visualize the enhancer-AS associations, we constructed a platform named VEnAS. VEnAS provides intuitive genomic architecture, association plot, and contingency table of all the significant enhancer-AS associations (Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>). To query VEnAS, users can input Ensembl gene ID or gene symbol (Query 1 in Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>). The auto-completion function would help users find out the gene of interests. The web server provides portable gene information for convenient linking to Ensembl, NCBI, and RefSeq (Result 1 in Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>). After users select an AS type and a corresponding enhancer (Query 2 in Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>), VEnAS shows the architecture of the gene with enhancer, association plot, and a two-by-two contingency table (Query 2 in Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>). For splicing display, the bending curve drawn above exons represents the inclusive form of AS products, while the curve drawn below exons represents the exclusive form. The width of curves represents the number of biological replicates which support the association events. Moreover, the colors denote whether enhancer is active or inactive. In the top of a two-by-two contingency table, the FDR adjusted <italic>q</italic>-value of the Fisher exact test and the odds ratio are also provided. Inside the table, the color boxes are representing biological replicates having AS shifted to inclusion or exclusion. The color intensity of the boxes is proportional to the Z-PSI. The tissue name and Z-PSI would be displayed when the mouse cursor is hovering atop the box. Additionally, VEnAS provides batch retrieval function. The user could send a list of Ensembl gene ID(s) obtained from any other analysis tool or software in the batch retrieval web page through pasting in dialog box or uploading file. VEnAS can convert the visualized results into PDF file format for users for further analyses.<fig id="Fig3"><label>Fig. 3</label><caption><p>The webpage of VEnAS and query steps. Following by the queries (e.g. Query 1 and 2), users can obtain gene architecture, association plot, and detailed statistical information (e.g. Result 1 and 2) of VEnAS database conveniently</p></caption><graphic xlink:href="12864_2022_8537_Fig3_HTML" id="MO3"/></fig></p>
    </sec>
  </sec>
  <sec id="Sec12">
    <title>Case study</title>
    <p id="Par37">We have identified lots of enhancer-AS associations in this study. However, it is difficult to find out large scale biological evaluation or literature evidence. Hence, we performed comparative genomics analysis between human and mouse as well as observed the splicing events to further evaluate the identified associations. Below is a case demonstrating the robustness of our finding. In Manduchi et al<italic>.</italic>âs study [<xref ref-type="bibr" rid="CR33">33</xref>], they identified 35 significant SNP marks and enhancers which are associated to Type 2 diabetes with combination of epigenomic markers and genome wide association studies (GWAS). In their result, gene ST3GAL4 is associated to two SNP markers located within an enhancer which is named chr11_1460 in our system. As shown in Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>A, the enhancer is marked by ENCODE as a <italic>cis</italic>-regulatory element in human. As shown in comparative genomics data track, the genomic region of this enhancer is located within synteny between human and mouse. In mouse, the associated enhancer is named chr9_3600, which is also marked as a <italic>cis</italic>-regulatory element by ENCODE and within the syntenic region shared with human enhancer chr11_1460 (Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>B). Furthermore, we utilized MISO to draw sashimi plots and PSI histograms [<xref ref-type="bibr" rid="CR26">26</xref>] to illustrate that the presence/absence of the associated enhancer is associated to skipped exon event (SE) of ST3GAL4 in human (Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>C). The PSI histograms show that all the PSI values are closed to â1â, <italic>i.e.</italic> the inclusive form dominated, in the samples where the enhancer is present. On the contrary, the PSI values are decreased to about 0.5 in the samples when the enhancer is absent. The strength of association between enhancer and SE is significant (<inline-formula id="IEq1"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$q-\mathrm{value}=2.909\mathrm{ x }{10}^{-2}$$\end{document}</tex-math><mml:math id="M4"><mml:mrow><mml:mi>q</mml:mi><mml:mo>-</mml:mo><mml:mi mathvariant="normal">value</mml:mi><mml:mo>=</mml:mo><mml:mn>2.909</mml:mn><mml:mi mathvariant="normal">x</mml:mi><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12864_2022_8537_Article_IEq1.gif"/></alternatives></inline-formula>, as shown in Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>D). Taking together the literature evidence, comparative genomics data, and PSI distribution; we did successfully demonstrate the existence of the enhancer-AS association.<fig id="Fig4"><label>Fig. 4</label><caption><p>Â A real case for the enhancer-AS association. The associated enhancers located in upstream of human gene ST3GAL4 (<bold>A</bold>) and mouse gene St3gal4 (<bold>B</bold>) marked by the red arrows. The tracks showing ENCODE <italic>cis</italic>-regulatory elements and genomic synteny between human and mouse are provided in the below. <bold>C</bold>Â The sashimi plots and PSI histograms of human ST3GAL4 2<sup>nd</sup> skipped exon (SE) event in 17 samples. The plots in red indicate that the samples having present associated enhancer chr11_1460, while the plots in green indicating the absence of chr11_1460. <bold>D</bold>Â The VEnAS result of 2<sup>nd</sup> SE event in ENSG00000110080 and associated enhancer chr11_1460. The location of enhancer indicated by red triangle in genomic architecture, association plot, and two-by-two contingency table are provided</p></caption><graphic xlink:href="12864_2022_8537_Fig4_HTML" id="MO4"/></fig></p>
  </sec>
  <sec id="Sec13">
    <title>Discussions</title>
    <p id="Par38">Previous studies showed that some enhancers are conserved between human and mouse [<xref ref-type="bibr" rid="CR34">34</xref>] while some enhancers might be reprogrammed after human-mouse speciation [<xref ref-type="bibr" rid="CR35">35</xref>]. To investigate whether the enhancers associated to AS existed in human and mouse are conserved or not, we further examined the conservation score difference between significant and insignificant enhancers. The conservation score of enhancer sequence between human and mouse were downloaded from Ensembl v94 compara 32 amniotes datasets [<xref ref-type="bibr" rid="CR36">36</xref>]. After comparison, we didnât find any difference of conservation score of enhancer sequence between significant and insignificant enhancer-AS associations (data not shown).</p>
    <p id="Par39">As we already know that enhancers could also serve as a hub for binding of transcription factors [<xref ref-type="bibr" rid="CR18">18</xref>], we tried to annotate known motifs on enhancer regions by DREME [<xref ref-type="bibr" rid="CR37">37</xref>] and TomTom [<xref ref-type="bibr" rid="CR38">38</xref>] with position frequency matrix from JASPAR [<xref ref-type="bibr" rid="CR39">39</xref>]. However, we didnât find any differentially enriched known motifs shared between human and mouse. Though we didnât find any advanced evidence, more data sets are required to conclude that the enhancers associated to AS are newly emerged or reprogrammed after human-mouse speciation.</p>
    <p id="Par40">In 2013, a new concept of super-enhancer had been proposed [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. Super-enhancers are considered to be a cluster of several different enhancers with exceptional higher binding of transcriptional coactivators [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. Super-enhancers are usually longer than typical enhancers, with a median length of 8.7Â kb [<xref ref-type="bibr" rid="CR42">42</xref>]. Recently, more and more super-enhancer databases about super-enhancer characteristics and associated genes are available, such as dbSUPER [<xref ref-type="bibr" rid="CR43">43</xref>], SEdb [<xref ref-type="bibr" rid="CR44">44</xref>], and SEA [<xref ref-type="bibr" rid="CR45">45</xref>]. It has been reported that super-enhancer is capable of regulating alternative splicing in smooth muscle [<xref ref-type="bibr" rid="CR46">46</xref>]. However, our current statistical analysis method is designed for one enhancer on one AS event rather than multiple/combinatorial enhancers on one AS event. To pin-point the correlation between the combination of transcription factors and AS events requires a more sophisticated method. In the future, we will pursue a genome-wide method to reveal the correlation between super-enhancer and alternative splicing event.</p>
  </sec>
  <sec id="Sec14">
    <title>Conclusion</title>
    <p id="Par41">In this study, an analysis pipeline to identify enhancer-AS associations was proposed. We included 84 RNA-seq data sets across 28 tissues and cell lines in human and 72 RNA-seq data sets across 24 tissues and cell lines in mouse for analysis. In total, 3,242 human genes and 7,716 mouse genes having at least one significant enhancer-AS were identified. On average, about 5â6% of the enhancers of one given gene are associated to AS change, and one given enhancer is associated to 1.28 human or 1.22 mouse genes. The significant enhancer-AS associations are more likely to be the co-existence of homologous genes and homologous enhancers in both human and mouse. Finally, we constructed VEnAS to provide comprehensive enhancer-associated AS results for scientists, including genomic architecture, intuitive association plot, and contingency table. We believe that our study is helpful in further understanding the roles of enhancers on regulating alternative splicing.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Information</title>
    <sec id="Sec15">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="12864_2022_8537_MOESM1_ESM.docx">
            <caption>
              <p><bold>Additional file 1:Â Figure S1. </bold>Thedetailed schema of data warehousing in MySQL. All the data tables includingcolumn names are illustrated. The primary keys for linking tables are depictedwith black lines.Â <bold>Figure S2. </bold>Thecomparison of sample similarity in skipped exon (SE).The Jaccardcoefficient index is pair-wisely computed to present the enhancer-AS similarityor overlapping between different samples. The number of enhancer-AS eventswhich have identical enhancer present/absent calling and the sameinclusive/exclusive AS shift are calculated, and then divided by the totalenhancer-AS events to compute the Jaccard coefficient index. The result showsthat the enhancer-AS events are different between tissues but quite similarwithin the triplicated samples under the same tissue type, except fetal stomachSRR980482 which has the lowest Jaccard index score comparing to the other twofetal stomach samples.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>A3SS</term>
        <def>
          <p id="Par4">Alternative 3â splice site</p>
        </def>
      </def-item>
      <def-item>
        <term>A5SS</term>
        <def>
          <p id="Par5">Alternative 5â splice site</p>
        </def>
      </def-item>
      <def-item>
        <term>AFE</term>
        <def>
          <p id="Par6">Alternative first exon</p>
        </def>
      </def-item>
      <def-item>
        <term>ALE</term>
        <def>
          <p id="Par7">Alternative last exon</p>
        </def>
      </def-item>
      <def-item>
        <term>AS</term>
        <def>
          <p id="Par8">Alternative splicing</p>
        </def>
      </def-item>
      <def-item>
        <term>ATSS</term>
        <def>
          <p id="Par9">Alternative transcription start site</p>
        </def>
      </def-item>
      <def-item>
        <term>ATTS</term>
        <def>
          <p id="Par10">Alternative transcription termination site</p>
        </def>
      </def-item>
      <def-item>
        <term>enhancer-AS</term>
        <def>
          <p id="Par11">Association between enhancer and alternative splicing</p>
        </def>
      </def-item>
      <def-item>
        <term>FDR</term>
        <def>
          <p id="Par12">BenjaminiâHochberg false discovery rate</p>
        </def>
      </def-item>
      <def-item>
        <term>GWAS</term>
        <def>
          <p id="Par13">Genome wide association study</p>
        </def>
      </def-item>
      <def-item>
        <term>MSE</term>
        <def>
          <p id="Par14">Multiple skipped exon</p>
        </def>
      </def-item>
      <def-item>
        <term>MXE</term>
        <def>
          <p id="Par15">Mutually exclusive exon</p>
        </def>
      </def-item>
      <def-item>
        <term>PSI</term>
        <def>
          <p id="Par16">Percent splice in</p>
        </def>
      </def-item>
      <def-item>
        <term>RI</term>
        <def>
          <p id="Par17">Retained intron</p>
        </def>
      </def-item>
      <def-item>
        <term>SE</term>
        <def>
          <p id="Par18">Skipped exon</p>
        </def>
      </def-item>
      <def-item>
        <term>SNP</term>
        <def>
          <p id="Par19">Single nucleotide polymorphism</p>
        </def>
      </def-item>
      <def-item>
        <term>SRE</term>
        <def>
          <p id="Par20">Splicing regulatory elements</p>
        </def>
      </def-item>
      <def-item>
        <term>Z-PSI</term>
        <def>
          <p id="Par21">Z-transformed PSI</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>Not applicable</p>
    <sec id="FPar1">
      <title>About this supplement</title>
      <p id="Par42">This article has been published as part of BMC Genomics Volume 22 Supplement 5 2021: Selected articles from the 19th Asia Pacific Bioinformatics Conference (APBC 2021): genomics The full contents of the supplement are available at <ext-link ext-link-type="uri" xlink:href="https://bmcgenomics.biomedcentral.com/articles/supplements/volume-22-supplement-5">https://bmcgenomics.biomedcentral.com/articles/supplements/volume-22-supplement-5</ext-link>.</p>
    </sec>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authorsâ contributions</title>
    <p>CKS, JHH and HKT designed the research. CKS collected the data sets and performed the research. CKS and YTL constructed database and website. CKS, JHH and HKT wrote the manuscript. All authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work has been supported by the Institute of Information Science, Academia Sinica and the Ministry of Science and Technology, Taiwan [MOST108-2221-E-001â014-MY3 to H.-K.T.]. Publication costs are also funded by the Institute of Information Science, Academia Sinica and the Ministry of Science and Technology, Taiwan [MOST108-2221-E-001â014-MY3 to H.-K.T.]. The funders did not play any role in the design of the study, the collection, analysis, and interpretation of data, or in writing of the manuscript.Ministry of Science and Technology,Taiwan,MOST108-2221-E-001-014-MY3,Huai-Kuang Tsai</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar2">
      <title>Ethics approval and consent to participate</title>
      <p id="Par43">Not applicable.</p>
    </notes>
    <notes id="FPar3">
      <title>Consent for publication</title>
      <p id="Par44">Not applicable.</p>
    </notes>
    <notes id="FPar4">
      <title>Availability of Data and Materials</title>
      <p id="Par45">All the raw datasets are downloaded from enhancerAtlas (<ext-link ext-link-type="uri" xlink:href="http://www.enhanceratlas.org">http://www.enhanceratlas.org</ext-link>) and SRA (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/">https://www.ncbi.nlm.nih.gov/sra/</ext-link>). The tissues and cell lines datasets used for the analysis are listed on the VEnAS web site (<ext-link ext-link-type="uri" xlink:href="http://venas.iis.sinica.edu.tw/">http://venas.iis.sinica.edu.tw/</ext-link>). The analysis result spreadsheets are available on VEnAS.</p>
      <p id="Par46">All the analysis pipeline and data source for analysis are available on GitHub: <ext-link ext-link-type="uri" xlink:href="https://github.com/shiauck/VEnAS">https://github.com/shiauck/VEnAS</ext-link>.</p>
    </notes>
    <notes id="FPar5" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par47">The authors declare that they have no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pan</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Shai</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Frey</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Blencowe</surname>
            <given-names>BJ</given-names>
          </name>
        </person-group>
        <article-title>Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing</article-title>
        <source>Nat Genet</source>
        <year>2008</year>
        <volume>40</volume>
        <issue>12</issue>
        <fpage>1413</fpage>
        <lpage>1415</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.259</pub-id>
        <?supplied-pmid 18978789?>
        <pub-id pub-id-type="pmid">18978789</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kriventseva</surname>
            <given-names>EV</given-names>
          </name>
          <name>
            <surname>Koch</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Apweiler</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Vingron</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bork</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Gelfand</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Sunyaev</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Increase of functional diversity by alternative splicing</article-title>
        <source>Trends Genet</source>
        <year>2003</year>
        <volume>19</volume>
        <issue>3</issue>
        <fpage>124</fpage>
        <lpage>128</lpage>
        <pub-id pub-id-type="doi">10.1016/S0168-9525(03)00023-4</pub-id>
        <?supplied-pmid 12615003?>
        <pub-id pub-id-type="pmid">12615003</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Weyn-Vanhentenryck</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ustianenko</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>DuffiÃ©</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Jacko</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Precise temporal regulation of alternative splicing during neural development</article-title>
        <source>Nat Commun</source>
        <year>2018</year>
        <volume>9</volume>
        <fpage>2189</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-018-04559-0</pub-id>
        <?supplied-pmid 29875359?>
        <pub-id pub-id-type="pmid">29875359</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yeo</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Holste</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Kreiman</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Burge</surname>
            <given-names>CB</given-names>
          </name>
        </person-group>
        <article-title>Variation in alternative splicing across human tissues</article-title>
        <source>Genome Biol</source>
        <year>2004</year>
        <volume>5</volume>
        <issue>10</issue>
        <fpage>R74</fpage>
        <pub-id pub-id-type="doi">10.1186/gb-2004-5-10-r74</pub-id>
        <?supplied-pmid 15461793?>
        <pub-id pub-id-type="pmid">15461793</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Noh</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Paik</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Hur</surname>
            <given-names>CG</given-names>
          </name>
        </person-group>
        <article-title>TISA: Tissue-specific Alternative Splicing in Human and Mouse Genes</article-title>
        <source>DNA Res</source>
        <year>2006</year>
        <volume>13</volume>
        <issue>5</issue>
        <fpage>229</fpage>
        <lpage>243</lpage>
        <pub-id pub-id-type="doi">10.1093/dnares/dsl011</pub-id>
        <?supplied-pmid 17107969?>
        <pub-id pub-id-type="pmid">17107969</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Planells</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>GÃ³mez-Redondo</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Pericuesta</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Lonergan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>GutiÃ©rrez-AdÃ¡n</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Differential isoform expression and alternative splicing in sex determination in mice</article-title>
        <source>BMC Genomics</source>
        <year>2019</year>
        <volume>20</volume>
        <fpage>202</fpage>
        <pub-id pub-id-type="doi">10.1186/s12864-019-5572-x</pub-id>
        <?supplied-pmid 30871468?>
        <pub-id pub-id-type="pmid">30871468</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gibilisco</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Mahajan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bachtrog</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Alternative Splicing within and between <italic>Drosophila</italic> Species, Sexes, Tissues, and Developmental Stages</article-title>
        <source>PLoS Genet.</source>
        <year>2016</year>
        <volume>12</volume>
        <issue>12</issue>
        <fpage>e1006464</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1006464</pub-id>
        <?supplied-pmid 27935948?>
        <pub-id pub-id-type="pmid">27935948</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Foret</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kucharski</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pellegrini</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jacobsen</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Robinson</surname>
            <given-names>GE</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DNA methylation dynamics, metabolic fluxes, gene splicing, and alternative phenotypes in honey bees</article-title>
        <source>Proc Natl Acad Sci U S A</source>
        <year>2012</year>
        <volume>109</volume>
        <issue>13</issue>
        <fpage>4968</fpage>
        <lpage>4973</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1202392109</pub-id>
        <?supplied-pmid 22416128?>
        <pub-id pub-id-type="pmid">22416128</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Systematical identification of splicing regulatory <italic>cis</italic>-elements and cognate <italic>trans</italic>-factors</article-title>
        <source>Methods</source>
        <year>2014</year>
        <volume>65</volume>
        <issue>3</issue>
        <fpage>350</fpage>
        <lpage>358</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ymeth.2013.08.019</pub-id>
        <?supplied-pmid 23974071?>
        <pub-id pub-id-type="pmid">23974071</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Holste</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ohler</surname>
            <given-names>U</given-names>
          </name>
        </person-group>
        <article-title>Strategies for Identifying RNA Splicing Regulatory Motifs and Predicting Alternative Splicing Events</article-title>
        <source>PLoS Comput Biol.</source>
        <year>2008</year>
        <volume>4</volume>
        <issue>1</issue>
        <fpage>e21</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pcbi.0040021</pub-id>
        <?supplied-pmid 18225947?>
        <pub-id pub-id-type="pmid">18225947</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kadener</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Fededa</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Rosbash</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kornblihtt</surname>
            <given-names>AR</given-names>
          </name>
        </person-group>
        <article-title>Regulation of alternative splicing by a transcriptional enhancer through RNA pol II elongation</article-title>
        <source>Proc Natl Acad Sci U S A</source>
        <year>2002</year>
        <volume>99</volume>
        <issue>12</issue>
        <fpage>8185</fpage>
        <lpage>8190</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.122246099</pub-id>
        <?supplied-pmid 12060763?>
        <pub-id pub-id-type="pmid">12060763</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Esumi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kakazu</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Taguchi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hirayama</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sasaki</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hirabayashi</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons</article-title>
        <source>Nat Genet</source>
        <year>2005</year>
        <volume>37</volume>
        <issue>2</issue>
        <fpage>171</fpage>
        <lpage>176</lpage>
        <pub-id pub-id-type="doi">10.1038/ng1500</pub-id>
        <?supplied-pmid 15640798?>
        <pub-id pub-id-type="pmid">15640798</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Reyes</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Huber</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Alternative start and termination sites of transcription drive most transcript isoform differences across human tissues</article-title>
        <source>Nucleic Acids Res</source>
        <year>2018</year>
        <volume>46</volume>
        <issue>2</issue>
        <fpage>582</fpage>
        <lpage>592</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1165</pub-id>
        <?supplied-pmid 29202200?>
        <pub-id pub-id-type="pmid">29202200</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pennacchio</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Bickmore</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Dean</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nobrega</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Bejerano</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Enhancers: five essential questions</article-title>
        <source>Nat Rev Genet</source>
        <year>2013</year>
        <volume>14</volume>
        <issue>4</issue>
        <fpage>288</fpage>
        <lpage>295</lpage>
        <pub-id pub-id-type="doi">10.1038/nrg3458</pub-id>
        <?supplied-pmid 23503198?>
        <pub-id pub-id-type="pmid">23503198</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hsiung</surname>
            <given-names>CCS</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Raj</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Blobel</surname>
            <given-names>GA</given-names>
          </name>
        </person-group>
        <article-title>Dynamic enhancerâgene body contacts during transcription elongation</article-title>
        <source>Genes Dev</source>
        <year>2015</year>
        <volume>29</volume>
        <issue>20</issue>
        <fpage>2217</fpage>
        <?supplied-pmid 26494793?>
        <pub-id pub-id-type="pmid">26494793</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schoenfelder</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Fraser</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Long-range enhancer-promoter contacts in gene expression control</article-title>
        <source>Nat Rev Genet</source>
        <year>2019</year>
        <volume>20</volume>
        <issue>8</issue>
        <fpage>437</fpage>
        <lpage>455</lpage>
        <pub-id pub-id-type="doi">10.1038/s41576-019-0128-0</pub-id>
        <?supplied-pmid 31086298?>
        <pub-id pub-id-type="pmid">31086298</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ong</surname>
            <given-names>CT</given-names>
          </name>
          <name>
            <surname>Corces</surname>
            <given-names>VG</given-names>
          </name>
        </person-group>
        <article-title>CTCF: An Architectural Protein Bridging Genome Topology and Function</article-title>
        <source>Nat Rev Genet</source>
        <year>2014</year>
        <volume>15</volume>
        <issue>4</issue>
        <fpage>234</fpage>
        <lpage>236</lpage>
        <pub-id pub-id-type="doi">10.1038/nrg3663</pub-id>
        <?supplied-pmid 24614316?>
        <pub-id pub-id-type="pmid">24614316</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Buecker</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wysocka</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Enhancers as information integration hubs in development: lessons from genomics</article-title>
        <source>Trends Genet</source>
        <year>2012</year>
        <volume>28</volume>
        <issue>6</issue>
        <fpage>276</fpage>
        <lpage>284</lpage>
        <pub-id pub-id-type="doi">10.1016/j.tig.2012.02.008</pub-id>
        <?supplied-pmid 22487374?>
        <pub-id pub-id-type="pmid">22487374</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gao</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Qian</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>EnhancerAtlas: a resource for enhancer annotation and analysis in 105 human cell/tissue types</article-title>
        <source>Bioinformatics</source>
        <year>2016</year>
        <volume>32</volume>
        <issue>23</issue>
        <fpage>3543</fpage>
        <lpage>3551</lpage>
        <?supplied-pmid 27515742?>
        <pub-id pub-id-type="pmid">27515742</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Leinonen</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sugawara</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>The Sequence Read Archive</article-title>
        <source>Nucleic Acids Res</source>
        <year>2011</year>
        <volume>39</volume>
        <issue>Suppl 1</issue>
        <fpage>D19</fpage>
        <lpage>21</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkq1019</pub-id>
        <?supplied-pmid 21062823?>
        <pub-id pub-id-type="pmid">21062823</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Paggi</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Bennett</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Salzberg</surname>
            <given-names>SL</given-names>
          </name>
        </person-group>
        <article-title>Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype</article-title>
        <source>Nat Biotechnol</source>
        <year>2019</year>
        <volume>37</volume>
        <issue>8</issue>
        <fpage>907</fpage>
        <lpage>915</lpage>
        <pub-id pub-id-type="doi">10.1038/s41587-019-0201-4</pub-id>
        <?supplied-pmid 31375807?>
        <pub-id pub-id-type="pmid">31375807</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>TK</given-names>
          </name>
          <name>
            <surname>Hemberg</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gray</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Costa</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Bear</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Widespread transcription at neuronal activity-regulated enhancers</article-title>
        <source>Nature</source>
        <year>2010</year>
        <volume>465</volume>
        <issue>7295</issue>
        <fpage>182</fpage>
        <lpage>187</lpage>
        <pub-id pub-id-type="doi">10.1038/nature09033</pub-id>
        <?supplied-pmid 20393465?>
        <pub-id pub-id-type="pmid">20393465</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>PodsiadÅo</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>WrzesieÅ</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Paja</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Rudnicki</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>WilczyÅski</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Active enhancer positions can be accurately predicted from chromatin marks and collective sequence motif data</article-title>
        <source>BMC Syst Biol</source>
        <year>2013</year>
        <volume>7</volume>
        <issue>Suppl 6</issue>
        <fpage>S16</fpage>
        <pub-id pub-id-type="doi">10.1186/1752-0509-7-S6-S16</pub-id>
        <?supplied-pmid 24565409?>
        <pub-id pub-id-type="pmid">24565409</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Whalen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Truty</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Pollard</surname>
            <given-names>KS</given-names>
          </name>
        </person-group>
        <article-title>Enhancer-promoter interactions are encoded by complex genomic signatures on looping chromatin</article-title>
        <source>Nat Genet</source>
        <year>2016</year>
        <volume>48</volume>
        <issue>5</issue>
        <fpage>488</fpage>
        <lpage>496</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.3539</pub-id>
        <?supplied-pmid 27064255?>
        <pub-id pub-id-type="pmid">27064255</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shiau</surname>
            <given-names>CK</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Tsai</surname>
            <given-names>HK</given-names>
          </name>
        </person-group>
        <article-title>CATANA: a tool for generating comprehensive annotations of alternative transcript events</article-title>
        <source>Bioinformatics</source>
        <year>2019</year>
        <volume>35</volume>
        <issue>8</issue>
        <fpage>1414</fpage>
        <lpage>1415</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bty795</pub-id>
        <?supplied-pmid 30202999?>
        <pub-id pub-id-type="pmid">30202999</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Katz</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>ET</given-names>
          </name>
          <name>
            <surname>Airoldi</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Burge</surname>
            <given-names>CB</given-names>
          </name>
        </person-group>
        <article-title>Analysis and design of RNA sequencing experiments for identifying isoform regulation</article-title>
        <source>Nat Methods</source>
        <year>2010</year>
        <volume>7</volume>
        <issue>12</issue>
        <fpage>1009</fpage>
        <lpage>1015</lpage>
        <pub-id pub-id-type="doi">10.1038/nmeth.1528</pub-id>
        <?supplied-pmid 21057496?>
        <pub-id pub-id-type="pmid">21057496</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Venables</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Klinck</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bramard</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Inkel</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Dufresne-Martin</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Koh</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Identification of alternative splicing markers for breast cancer</article-title>
        <source>Cancer Res</source>
        <year>2008</year>
        <volume>68</volume>
        <issue>22</issue>
        <fpage>9525</fpage>
        <lpage>9531</lpage>
        <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-1769</pub-id>
        <?supplied-pmid 19010929?>
        <pub-id pub-id-type="pmid">19010929</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yue</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>McCleary</surname>
            <given-names>DF</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Edsall</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Kuan</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A map of the <italic>cis</italic>-regulatory sequences in the mouse genome</article-title>
        <source>Nature</source>
        <year>2012</year>
        <volume>488</volume>
        <fpage>116</fpage>
        <lpage>120</lpage>
        <pub-id pub-id-type="doi">10.1038/nature11243</pub-id>
        <?supplied-pmid 22763441?>
        <pub-id pub-id-type="pmid">22763441</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <mixed-citation publication-type="other">Fishilevich S, Nudel R, Rappaport N, Hadar R, Plaschkes I, Stein TI, <italic>et al</italic>. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database. 2017;2017:bax028.</mixed-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bult</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Blake</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>CL</given-names>
          </name>
          <name>
            <surname>Kadin</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Richardson</surname>
            <given-names>JE</given-names>
          </name>
        </person-group>
        <article-title>the Mouse Genome Database Group. Mouse Genome Database (MGD) 2019. 2019</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>D1</issue>
        <fpage>D801</fpage>
        <lpage>6</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1056</pub-id>
        <?supplied-pmid 30407599?>
        <pub-id pub-id-type="pmid">30407599</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kocher</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>CrossMap: a versatile tool for coordinate conversion between genome assemblies</article-title>
        <source>Bioinformatics</source>
        <year>2014</year>
        <volume>30</volume>
        <issue>7</issue>
        <fpage>1006</fpage>
        <lpage>1007</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btt730</pub-id>
        <?supplied-pmid 24351709?>
        <pub-id pub-id-type="pmid">24351709</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <mixed-citation publication-type="other">UCSC chain file from hg19 (GRCh37) to mm9 (GRCm37). <ext-link ext-link-type="uri" xlink:href="http://hgdownload.soe.ucsc.edu/goldenPath/hg19/liftOver/hg19ToMm9.over.chain.gz">http://hgdownload.soe.ucsc.edu/goldenPath/hg19/liftOver/hg19ToMm9.over.chain.gz</ext-link>. Accessed 21 Sep 2020.</mixed-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Manduchi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Williams</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Chesi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Wells</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Grant</surname>
            <given-names>SFA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Leveraging epigenomics and contactomics data to investigate SNP pairs in GWAS</article-title>
        <source>Hum Genet</source>
        <year>2018</year>
        <volume>137</volume>
        <fpage>413</fpage>
        <lpage>415</lpage>
        <pub-id pub-id-type="doi">10.1007/s00439-018-1893-0</pub-id>
        <?supplied-pmid 29797095?>
        <pub-id pub-id-type="pmid">29797095</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vilar</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Berthelot</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Aldridge</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rayner</surname>
            <given-names>TF</given-names>
          </name>
          <name>
            <surname>Lukk</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pignatelli</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Enhancer evolution across 20 mammalian species</article-title>
        <source>Cell</source>
        <year>2015</year>
        <volume>160</volume>
        <issue>3</issue>
        <fpage>554</fpage>
        <lpage>566</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2015.01.006</pub-id>
        <pub-id pub-id-type="pmid">25635462</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Flores</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Ovcharenko</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>Enhancer reprogramming in mammalian genomes</article-title>
        <source>BMC Bioinformatics</source>
        <year>2018</year>
        <volume>19</volume>
        <fpage>316</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-018-2343-7</pub-id>
        <?supplied-pmid 30200877?>
        <pub-id pub-id-type="pmid">30200877</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cooper</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Stone</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Asimenos</surname>
            <given-names>G</given-names>
          </name>
          <collab>NISC Comparative Sequencing Program, Green ED</collab>
          <name>
            <surname>Batzoglou</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Distribution and intensity of constraint in mammalian genomic sequence</article-title>
        <source>Genome Res</source>
        <year>2005</year>
        <volume>15</volume>
        <issue>7</issue>
        <fpage>901</fpage>
        <lpage>13</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.3577405</pub-id>
        <?supplied-pmid 15965027?>
        <pub-id pub-id-type="pmid">15965027</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bailey</surname>
            <given-names>TL</given-names>
          </name>
        </person-group>
        <article-title>DREME: motif discovery in transcription factor ChIP-seq data</article-title>
        <source>Bioinformatics</source>
        <year>2011</year>
        <volume>27</volume>
        <issue>12</issue>
        <fpage>1653</fpage>
        <lpage>1659</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btr261</pub-id>
        <?supplied-pmid 21543442?>
        <pub-id pub-id-type="pmid">21543442</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gupta</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Stamatoyannopoulos</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Bailey</surname>
            <given-names>TL</given-names>
          </name>
          <name>
            <surname>Noble</surname>
            <given-names>WS</given-names>
          </name>
        </person-group>
        <article-title>Quantifying similarity between motifs</article-title>
        <source>Genome Biol</source>
        <year>2007</year>
        <volume>8</volume>
        <issue>2</issue>
        <fpage>R24</fpage>
        <pub-id pub-id-type="doi">10.1186/gb-2007-8-2-r24</pub-id>
        <?supplied-pmid 17324271?>
        <pub-id pub-id-type="pmid">17324271</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fornes</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Castro-Mondragon</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Khan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>RVD</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Richmond</surname>
            <given-names>PA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>JASPAR 2020: update of the open-access database of transcription factor binding profiles</article-title>
        <source>Nucleic Acids Res</source>
        <year>2020</year>
        <volume>48</volume>
        <issue>D1</issue>
        <fpage>D87</fpage>
        <lpage>92</lpage>
        <?supplied-pmid 31701148?>
        <pub-id pub-id-type="pmid">31701148</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Whyte</surname>
            <given-names>WA</given-names>
          </name>
          <name>
            <surname>Orlando</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Hnisz</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Abraham</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Kagey</surname>
            <given-names>MH</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes</article-title>
        <source>Cell</source>
        <year>2013</year>
        <volume>153</volume>
        <issue>2</issue>
        <fpage>307</fpage>
        <lpage>319</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2013.03.035</pub-id>
        <?supplied-pmid 23582322?>
        <pub-id pub-id-type="pmid">23582322</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <mixed-citation publication-type="other">Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, et al. Transcriptional super-enhancers connected to cell identity and disease. Cell. 2013;155(4): 10.1016/j.cell.2013.09.053.</mixed-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moorthy</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Davidson</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Shchuka</surname>
            <given-names>VM</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Malek-Gilani</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Langroudi</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Enhancers and super-enhancers have an equivalent regulatory role in embryonic stem cells through regulation of single or multiple genes</article-title>
        <source>Genome Res</source>
        <year>2017</year>
        <volume>27</volume>
        <issue>2</issue>
        <fpage>246</fpage>
        <lpage>258</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.210930.116</pub-id>
        <?supplied-pmid 27895109?>
        <pub-id pub-id-type="pmid">27895109</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Khan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>dbSUPER: a database of super-enhancers in mouse and human genome</article-title>
        <source>Nucleic Acids Res</source>
        <year>2016</year>
        <volume>44</volume>
        <issue>D1</issue>
        <fpage>D164</fpage>
        <lpage>D171</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkv1002</pub-id>
        <?supplied-pmid 26438538?>
        <pub-id pub-id-type="pmid">26438538</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Qian</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Bai</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Ai</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>SEdb: a comprehensive human super-enhancer database</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>D1</issue>
        <fpage>D235</fpage>
        <lpage>D243</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1025</pub-id>
        <?supplied-pmid 30371817?>
        <pub-id pub-id-type="pmid">30371817</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Gu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>SEA version 3.0: a comprehensive extension and update of the Super-Enhancer archive</article-title>
        <source>Nucleic Acids Res</source>
        <year>2020</year>
        <volume>48</volume>
        <issue>D1</issue>
        <fpage>D198</fpage>
        <lpage>203</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkz757</pub-id>
        <?supplied-pmid 31667506?>
        <pub-id pub-id-type="pmid">31667506</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nakagaki-Silva</surname>
            <given-names>EE</given-names>
          </name>
          <name>
            <surname>Gooding</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Llorian</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jacob</surname>
            <given-names>AG</given-names>
          </name>
          <name>
            <surname>Richards</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Buckroyd</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Identification of RBPMS as a mammalian smooth muscle master splicing regulator via proximity of its gene with super-enhancers</article-title>
        <source>eLife</source>
        <year>2019</year>
        <volume>8</volume>
        <fpage>e46327</fpage>
        <pub-id pub-id-type="doi">10.7554/eLife.46327</pub-id>
        <?supplied-pmid 31283468?>
        <pub-id pub-id-type="pmid">31283468</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
